14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
EBS vs EHTH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Emergent Biosolutions, Inc. (EBS) is the stronger overall head-to-head candidate over eHealth, Inc. (EHTH) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). EBS carries a Unified Composite Score of 54.3/100 (HOLD) at $5.63 (20.0x Forward P/E, 5.8% operating margin), whereas EHTH carries 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin).
Technical & Structure Timing Caution: EBS trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 37.8); meanwhile EHTH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EBS vs EHTH. Trailing 12-month operating profitability (EBS 5.8% vs EHTH 11.9%) and valuation multiples (EBS 20.0x vs EHTH 0.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance Brokers value chain with $13.4M market capitalization and 11.9% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ EBS vs EHTH Key Questions & Quantitative Answers
As of Nov 17, 2026, Emergent Biosolutions, Inc. (EBS) is the stronger overall head-to-head candidate over eHealth, Inc. (EHTH) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). EBS carries a Unified Composite Score of 54.3/100 (HOLD) at $5.63 (20.0x Forward P/E, 5.8% operating margin), whereas EHTH carries 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin). Technical & Structure Timing Caution: EBS trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 37.8); meanwhile EHTH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
EBS leads the Growth & Scale pillar: EBS posts -52.4% YoY revenue growth and -93.8% YoY earnings growth on $649M TTM revenue (43.4% gross margin, 5.8% operating margin), compared with EHTH at -60.5% YoY revenue growth and -17.6% YoY earnings growth on $469M TTM revenue (100.0% gross margin, 11.9% operating margin). On trailing 12-month operating scale, EBS generates $649M in USD-normalized revenue versus $469M for EHTH. In operating R&D and SG&A reinvestment, EBS deploys 37.6% of Rev ($244M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for EHTH.
EHTH screens cheaper on headline valuation multiples. EBS trades at 20.0x Forward P/E, 20.0x Trailing P/E, 0.38x PEG, and 1.0x EV/Revenue (29.0% FCF margin), whereas EHTH trades at 0.2x Forward P/E, 0.2x Trailing P/E, 0.72x PEG, and N/M EV/Revenue (12.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EBS (-58.2% ROE) versus EHTH (2.6% ROE) capital efficiency.
In options market volatility and institutional positioning, EBS carries 73.2% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.07x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.81β · 49% Vol realized risk). By comparison, EHTH carries 128.7% implied volatility (56th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 117% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.